Septerna (SEPN) Tax Provisions (2024 - 2026)

Septerna (SEPN) recorded quarterly Tax Provisions of $337000.0 in Q1 2026, up 2708.33% quarter-over-quarter from $12000.0 in Q4 2025.

Septerna (SEPN) Tax Provisions (2024 - 2026) Analysis & Trends

Septerna's Tax Provisions history runs 3 years deep, the most recent figure standing at $337000.0 for Q1 2026.

  • In Q1 2026, Tax Provisions changed N/A year-over-year to $337000.0; the TTM figure through Mar 2026 stood at $349000.0 (up 286.63% YoY), while the FY2025 annual figure was $12000.0, up 102.41% from the prior year.
  • Tax Provisions was $337000.0 for Q1 2026 at Septerna, up from $12000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $337000.0 in Q1 2026 to a low of -$160000.0 in Q4 2024.
  • Historically, Tax Provisions has averaged $42500.0 across 3 years, with a median of $52500.0 in 2024.
  • Biggest YoY gain for Tax Provisions was 107.5% in 2025; the steepest drop was 107.5% in 2025.
  • A 3-year view of Tax Provisions shows it stood at -$160000.0 in 2024, then soared by 107.5% to $12000.0 in 2025, then soared by 2708.33% to $337000.0 in 2026.
  • The last three Tax Provisions figures came in at $337000.0 (Q1 2026), $12000.0 (Q4 2025), and -$160000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -11.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 216,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Septerna 1.62 Bn 1.62 Bn - 337,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 337,000.00
Dec 31, 2025 12,000.00
Dec 31, 2024 -160,000.00
Sep 30, 2024 -136,000.00
Jun 30, 2024 109,000.00
Mar 31, 2024 93,000.00